Opiate tolerance and dependence are complex phenomena, and may involve, in part, alterations in endogenous opioid peptide concentrations. We will examine the effects of chronic mu opiate receptor agonists on concentrations of endogenous opioid peptides and mu opiate receptors.
Specific Aim I will address the effects of chronic of morphine, endomorphin-1 and 2 (two newly discovered endogenous mu agonists) on the levels of mu receptors, endomorphin-1 and 2 in SH-SYSY cells, using radioimmunoassay (with antibodies generated and characterized in this lab).
Specific Aim II will address the effects of chronic morphine, and endomorphin-1 and -2 administration on the levels of mu receptors and endomorphin- l and 2 in the rat spinal cord, using immunocytochemistry. In order to examine the mu opiate receptor's role in regulating endomorphin-1 and 2 peptide levels, in Specific Aim III, we will inactivate the mu opiate receptor in the rat spinal cord, and analyze the changes in endomorphin- I and 2 levels, using immunocytochemistry. Elucidation of the effects of chronic opiate administration on endogenous opioid peptide systems will help us to develop an understanding of the mechanisms of opiate tolerance and dependence.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31DA005907-03
Application #
6378435
Study Section
Special Emphasis Panel (ZDA1-MXS-M (09))
Program Officer
Babecki, Beth
Project Start
2001-03-15
Project End
Budget Start
2001-03-15
Budget End
2002-03-14
Support Year
3
Fiscal Year
2001
Total Cost
$20,585
Indirect Cost
Name
Tulane University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118